Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
-831K
-
Total reported value, excl. options
-
$230M
-
Value change
-
-$37.8M
-
Number of buys
-
37
-
Number of sells
-
-23
-
Price
-
$6.18
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2022
76 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q1 2022.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 47.6M outstanding shares and own 78.14% of the company stock.
Largest 10 shareholders include Bellevue Group AG (5.03M shares), Soleus Capital Management, L.P. (4.22M shares), EVENTIDE ASSET MANAGEMENT, LLC (4.17M shares), BVF INC/IL (3.7M shares), JANUS HENDERSON GROUP PLC (3.47M shares), RTW INVESTMENTS, LP (2.64M shares), Avidity Partners Management LP (2.46M shares), Blackstone Inc. (2M shares), MORGAN STANLEY (1.55M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.54M shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.